The use of afala in complex treatment of patients with chronic prostatitis improves the efficiency of therapy and prolongs its positive results. The preparation is well tolerated, has no contraindication, and can be combined with other drugs. Afala is indicated for patients with stages II and IIIa chronic prostatitis from the first day of therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10517-009-0693-xDOI Listing

Publication Analysis

Top Keywords

chronic prostatitis
12
afala complex
8
patients chronic
8
efficiency afala
4
complex therapy
4
therapy patients
4
prostatitis afala
4
complex treatment
4
treatment patients
4
prostatitis improves
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!